TAVR: Reasons to Consider Mitral Annular Calcification

Courtesy of Dr. Carlos Fava.

TAVR: Reasons to Consider Mitral Annular CalcificationAortic valve calcification and mitral annular calcification have the same etiology and are frequently present in high-risk patients undergoing transcatheter aortic valve replacement (TAVR). The implications of mitral annular calcification for patients undergoing TAVR has not been entirely clarified yet.

 

The study examined 782 patients with severe aortic stenosis who underwent TAVR. Among these patients, 375 (49.9%) presented mitral annular calcification in the computerized tomography scan:

  • Mild: 30.4%
  • Moderate: 9.5%
  • Severe: 9.5%

 

Patients who experienced the highest rate of mitral annular calcification were the eldest (83 vs. 81.9 years old), those with chronic renal insufficiency, and those with a higher Society of Thoracic Surgeons (STS) score (8.8 vs. 7.5; p <0,001).

 

Procedural success was similar for all patients, and no differences in mortality and major complications were observed at 30 daysAt 1 year, severe mitral annular calcification was found to be an independent predictor of all-cause mortality (hazard ratio [HR]: 1.95; 95% confidence interval [CI]: 1.24-3.07; p = 0.004) and cardiovascular mortality (HR: 2.35; 95% CI: 1.19-4.66; p = 0.01). Furthermore, it was an independent predictor of the need for a new permanent pacemaker after TAVR (odds ratio [OR]: 2.83; 95% CI: 1.08-7.47; p = 0.03).

 

Conclusion

Half of the patients with severe aortic stenosis experience mitral annular calcification. Severe mitral annular calcification is associated with increased all-cause and cardiovascular mortality, and with conduction disorders after TAVR. This pathology should be included in future risk stratification models.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Original title: Concomitant Mitral Annular Calcification and Severe Aortic Stenosis: Prevalence, Characteristics and Outcome Following Transcatheter Aortic Valve Replacement.

Reference: Yigal Abramowitz, et al. European Heart Journal Advance Access published December 30, 2016.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...